Avantor Inc (AVTR)
20.86
-0.29
(-1.37%)
USD |
NYSE |
Nov 15, 11:15
Avantor Free Cash Flow: 747.20M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 747.20M |
| June 30, 2024 | 736.20M |
| March 31, 2024 | 639.00M |
| December 31, 2023 | 723.60M |
| September 30, 2023 | 694.60M |
| June 30, 2023 | 720.90M |
| March 31, 2023 | 774.00M |
| December 31, 2022 | 710.20M |
| September 30, 2022 | 799.20M |
| June 30, 2022 | 809.20M |
| March 31, 2022 | 858.40M |
| December 31, 2021 | 842.50M |
| Date | Value |
|---|---|
| September 30, 2021 | 867.30M |
| June 30, 2021 | 904.20M |
| March 31, 2021 | 739.50M |
| December 31, 2020 | 868.20M |
| September 30, 2020 | 657.30M |
| June 30, 2020 | 575.90M |
| March 31, 2020 | 480.30M |
| December 31, 2019 | 302.40M |
| September 30, 2019 | 292.00M |
| June 30, 2019 | 206.20M |
| March 31, 2019 | 191.50M |
| December 31, 2018 | 162.80M |
Free Cash Flow Range, Past 5 Years
302.40M
Minimum
Dec 2019
904.20M
Maximum
Jun 2021
722.50M
Average
737.85M
Median
Free Cash Flow Benchmarks
| Revvity Inc | 564.37M |
| Bruker Corp | 156.70M |
| Azenta Inc | 40.93M |
| Harvard Bioscience Inc | 0.16M |
| Bionano Genomics Inc | -106.10M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 244.80M |
| Cash from Investing (Quarterly) | -40.50M |
| Cash from Financing (Quarterly) | -198.60M |
| Free Cash Flow Per Share (Quarterly) | 0.2987 |
| Free Cash Flow to Equity (Quarterly) | 397.90M |
| Free Cash Flow to Firm (Quarterly) | 241.78M |
| Free Cash Flow Yield | 5.26% |